1. Home
  2. LXRX vs RGP Comparison

LXRX vs RGP Comparison

Compare LXRX & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • RGP
  • Stock Information
  • Founded
  • LXRX 1995
  • RGP 1996
  • Country
  • LXRX United States
  • RGP United States
  • Employees
  • LXRX N/A
  • RGP N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • RGP Business Services
  • Sector
  • LXRX Health Care
  • RGP Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • RGP Nasdaq
  • Market Cap
  • LXRX 283.7M
  • RGP 263.4M
  • IPO Year
  • LXRX 2000
  • RGP 2006
  • Fundamental
  • Price
  • LXRX $0.71
  • RGP $7.51
  • Analyst Decision
  • LXRX Buy
  • RGP Hold
  • Analyst Count
  • LXRX 2
  • RGP 3
  • Target Price
  • LXRX $4.00
  • RGP $13.00
  • AVG Volume (30 Days)
  • LXRX 4.1M
  • RGP 242.2K
  • Earning Date
  • LXRX 03-10-2025
  • RGP 04-02-2025
  • Dividend Yield
  • LXRX N/A
  • RGP 7.43%
  • EPS Growth
  • LXRX N/A
  • RGP N/A
  • EPS
  • LXRX N/A
  • RGP N/A
  • Revenue
  • LXRX $5,229,000.00
  • RGP $582,058,000.00
  • Revenue This Year
  • LXRX $842.94
  • RGP N/A
  • Revenue Next Year
  • LXRX $19.76
  • RGP $20.70
  • P/E Ratio
  • LXRX N/A
  • RGP N/A
  • Revenue Growth
  • LXRX 886.60
  • RGP N/A
  • 52 Week Low
  • LXRX $0.62
  • RGP $7.49
  • 52 Week High
  • LXRX $2.83
  • RGP $14.29
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 43.33
  • RGP 31.43
  • Support Level
  • LXRX $0.66
  • RGP $7.70
  • Resistance Level
  • LXRX $0.97
  • RGP $8.00
  • Average True Range (ATR)
  • LXRX 0.07
  • RGP 0.23
  • MACD
  • LXRX -0.00
  • RGP -0.07
  • Stochastic Oscillator
  • LXRX 16.13
  • RGP 2.04

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

Share on Social Networks: